Back to Search Start Over

Inflammatory Response and Defects on Myelin Integrity in the Olfactory System of K18hACE2 Mice Infected with SARS-CoV-2.

Authors :
Martin-Lopez E
Brennan B
Mao T
Spence N
Meller SJ
Han K
Yahiaoui N
Wang C
Iwasaki A
Greer CA
Source :
ENeuro [eNeuro] 2024 Jun 17; Vol. 11 (6). Date of Electronic Publication: 2024 Jun 17 (Print Publication: 2024).
Publication Year :
2024

Abstract

Viruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), use respiratory epithelial cells as an entry point for infection. Within the nasal cavity, the olfactory epithelium (OE) is particularly sensitive to infections which may lead to olfactory dysfunction. In patients suffering from coronavirus disease 2019, deficits in olfaction have been characterized as a distinctive symptom. Here, we used the K18hACE2 mice to study the spread of SARS-CoV-2 infection and inflammation in the olfactory system (OS) after 7 d of infection. In the OE, we found that SARS-CoV-2 selectively targeted the supporting/sustentacular cells (SCs) and macrophages from the lamina propria. In the brain, SARS-CoV-2 infected some microglial cells in the olfactory bulb (OB), and there was a widespread infection of projection neurons in the OB, piriform cortex (PC), and tubular striatum (TuS). Inflammation, indicated by both elevated numbers and morphologically activated IBA1 <superscript>+</superscript> cells (monocyte/macrophage lineages), was preferentially increased in the OE septum, while it was homogeneously distributed throughout the layers of the OB, PC, and TuS. Myelinated OS axonal tracts, the lateral olfactory tract, and the anterior commissure, exhibited decreased levels of 2',3'-cyclic-nucleotide 3'-phosphodiesterase, indicative of myelin defects. Collectively, our work supports the hypothesis that SARS-CoV-2 infected SC and macrophages in the OE and, centrally, microglia and subpopulations of OS neurons. The observed inflammation throughout the OS areas and central myelin defects may account for the long-lasting olfactory deficit.<br />Competing Interests: E.M-L., T.M., B.B., N.S., S.J.M., K.H., N.Y., C.W., and C.A.G. authors declare no competing financial interests. A.I. co-founded RIGImmune, Xanadu Bio, and PanV and is a member of the Board of Directors of Roche Holding and Genentech.<br /> (Copyright © 2024 Martin-Lopez et al.)

Details

Language :
English
ISSN :
2373-2822
Volume :
11
Issue :
6
Database :
MEDLINE
Journal :
ENeuro
Publication Type :
Academic Journal
Accession number :
38834299
Full Text :
https://doi.org/10.1523/ENEURO.0106-24.2024